Med. praxi. 2026;23(3):188-192 | DOI: 10.36290/med.2026.026

Climacteric health issues: different diagnosic and treatment options

MUDr. Jana Racková
Gynovum, s. r. o., soukromá gynekologická ambulance, Praha

Perimenopause and menopause represent key phases of reproductive aging in women, triggering endocrine, metabolic and cellular changes. Traditionally, they have been perceived primarily as hormonally conditioned processes with the occurrence of vasomotor symptoms. Current findings show that menopause reflects a broader biological aging process involving molecular and systemic alterations. The associated hormonal imbalance contributes to bone loss, central fat accumulation, changes in the urogenital, immune and nervous systems with an increased cardiovascular risk. The menopausal period also predisposes women to type 2 diabetes and metabolic syndrome. The therapeutic plan must be individualized according to the phase of reproductive aging. The period of middle age places an extreme physical and psychological burden on women with all its socio-economic consequences.

Keywords: perimenopause, menopause, menopausal hormone therapy, obesity, musculoskeletal syndrome.

Received: May 12, 2026; Revised: June 5, 2026; Accepted: June 5, 2026; Published: June 22, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Racková J. Climacteric health issues: different diagnosic and treatment options. Med. praxi. 2026;23(3):188-192. doi: 10.36290/med.2026.026.
Download citation

References

  1. Santoro N. Perimenopause: From Research to Practice. J Womens Health (Larchmt). 2016;25(4):332-339. Go to original source... Go to PubMed...
  2. Kirubarajan A, Sohel N, Mayhew A, et al. The association between primary ovarian insufficiency and increased multimorbidity in a large prospective cohort (Canadian Longitudinal Study on Aging). Fertil Steril. 2025;123(2):289-299. Go to original source... Go to PubMed...
  3. Zhu D, Chung HF, Dobson AJ, et al. Vasomotor menopausal symptoms and risk of cardiovascular disease: a pooled analysis of six prospective studies. Am J Obstet Gynecol. 2020;223(6):898.e1-898.e16. Go to original source... Go to PubMed...
  4. Camaioni A, Ucci MA, Campagnolo L, et al. The process of ovarian aging: it is not just about oocytes and granulosa cells. J Assist Reprod Genet. 2022;39(4):783-792. Go to original source...
  5. Cutts BA, Fennessy K. Addressing the perimenopause: what's blood got to do with it? Res Pract Thromb Haemost. 2025;9(2):102698. Go to original source...
  6. Patel P, Patil S, Kaur N. Estrogen and Metabolism: Navigating Hormonal Transitions from Perimenopause to Postmenopause. J Midlife Health. 2025;16(3):247-256. Go to original source... Go to PubMed...
  7. Panay N, Ang SB, Cheshire R, et al. Menopause and MHT in 2024: addressing the key controversies - an International Menopause Society White Paper. Climacteric. 2024;27(5):441-457. Go to original source... Go to PubMed...
  8. Lumsden MA, Dekkers OM, Faubion SS, et al. European Society of Endocrinology clinical practice guideline for evaluation and management of menopause and the perimenopause. Eur J Endocrinol. 2025;193(4):G49-G81. Go to original source... Go to PubMed...
  9. Thurston RC, Aslanidou Vlachos HE, Derby CA, et al. Menopausal Vasomotor Symptoms and Risk of Incident Cardiovascular Disease Events in SWAN. J Am Heart Assoc. 2021;10(3):e017416. Go to original source...
  10. Vrablík M. Cévní onemocnění žen v menopauze. Med Praxi. 2014;11(6):249-253.
  11. Crandall CJ, Mehta JM, Manson JE. Management of Menopausal Symptoms: A Review. JAMA. 2023;329(5):405-420. Go to original source...
  12. O'Neill MT, Jones V, Reid A. Impact of menopausal symptoms on work and careers: a cross-sectional study. Occup Med (Lond). 2023;73(6):332-338. Go to original source... Go to PubMed...
  13. Racková J. Effect of kisspeptin, neurokinin, and dynorphin neurons on regulation of reproduction. Ceska Gynekol. 2025;90(5):413-417. Go to original source... Go to PubMed...
  14. Cybulska AM, Rachubińska K, Grochans E, et al. Systemic Inflammation Indices, Chemokines, and Metabolic Markers in Perimenopausal Women. Nutrients. 2025;17(17):2885. Go to original source... Go to PubMed...
  15. Waliszewska-Prosół M, Grandi G, Ornello R, et al. Menopause, Perimenopause, and Migraine: Understanding the Intersections and Implications for Treatment. Neurol Ther. 2025;14(3):665-680. Go to original source... Go to PubMed...
  16. Marano G, d'Abate C, Ianes I, et al. The Gut Microbiota in Perimenopausal Anxiety: A Novel Therapeutic Pathway Through Diet. Nutrients. 2026;18(5):743. Go to original source...
  17. Shariati-Sarabi Z, Rezaie HE, Milani N, et al. Evaluation of Bone Mineral Density in Perimenopausal Period. Arch Bone Jt Surg. 2018;6(1):57-62.
  18. Wright VJ, Schwartzman JD, Itinoche R, et al. The musculoskeletal syndrome of menopause. Climacteric. 2024;27(5):466-472. Go to original source... Go to PubMed...
  19. Navarro VM. Metabolic regulation of kisspeptin - the link between energy balance and reproduction. Nat Rev Endocrinol. 2020 Aug;16(8):407-420. doi: 10.1038/s41574-020-0363-7. Go to original source...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.